小儿肺炎支原体感染临床检验的诊断价值分析

Diagnostic value of clinical examination of Mycoplasma pneumoniae infection in children

ES评分 0

DOI 10.12208/j.imrf.20220089
刊名
International Medical Research Frontier
年,卷(期) 2022, 6(2)
作者
作者单位

东明县胡庄卫生服务中心 山东菏泽 ;

摘要
分析小儿肺炎支原体感染患儿接受临床检验的相关作用。方法 从2020年1月-2022年1月区间内因小儿肺炎入院接受诊治的患儿内随机选择100例研究,对整体患儿实施回顾性分析,分析患儿的临床检验结果。结果 100例患儿内,经过MP-IgM检测结果发现,MP-IgM阳性人数为37例,检出率为37%。37例患儿内,上呼吸道感染的患儿为14例,支气管炎的患儿为10例,支气管肺炎的人数为6例,支气管哮喘的为4例。痰液检查阳性的患儿人数为23例,检出率为23%,其中肺炎链球菌为11例,肺炎克雷伯菌为8例,阴沟肠杆菌为4例。男性患儿MP-IgM检出率为45.95%,女性患儿MP-IgM检出率为54.05%,女性稍高于男性,但对比无显著差异,P>0.05。结论 小儿肺炎支原体感染后接受临床检验,可以为临床工作提供部分参考,但最终的检查仍需结合其他数据。
Abstract
Objective to analyze the related role of clinical examination in children with Mycoplasma pneumoniae infection. Methods from January 2020 to January 2022, 100 children with pediatric pneumonia were randomly selected for study. The whole children were analyzed retrospectively and the clinical test results were analyzed. Results in 100 children, the detection results of MP IgM showed that 37 cases were MP IgM positive, and the detection rate was 37%. Among the 37 children, there were 14 children with upper respiratory tract infection, 10 children with bronchitis, 6 children with bronchopneumonia and 4 children with bronchial asthma. The number of children with positive sputum test was 23, and the detection rate was 23%, including 11 cases of Streptococcus pneumoniae, 8 cases of Klebsiella pneumoniae and 4 cases of Enterobacter cloacae. The detection rate of MP IgM in male children was 45.95%, and that in female children was 54.05%. Women were slightly higher than men, but there was no significant difference (P > 0.05). Conclusion clinical examination after Mycoplasma pneumoniae infection in children can provide some reference for clinical work, but the final examination still needs to be combined with other data.
关键词
小儿肺炎;支原体感染;临床检验;诊断价值
KeyWord
Pediatric pneumonia; Mycoplasma infection; Clinical examination; Diagnostic value
基金项目
页码 164-166
  • 参考文献
  • 相关文献
  • 引用本文

董风民*. 小儿肺炎支原体感染临床检验的诊断价值分析 [J]. 国际医药研究前沿. 2022; 6; (2). 164 - 166.

  • 文献评论

相关学者

相关机构